Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide ...

The US Food and Drug Administration (FDA) has approved Neurelis’ diazepam nasal spray, Valtoco, for the short-term treatment ...

The ACIP has voted to recommend the use of respiratory syncytial virus (RSV) vaccines for adults aged 50 to 59.

Glycomine’s Series C raise highlights investor confidence in the company amid pressure on the paediatric rare disease sector.

The executive order aims to lower prescription prices, but targets the mechanism for negotiating small molecule drug costs.

Eisai and Biogen have received marketing authorisation from the European Commission (EC) for Leqembi (lecanemab) to treat ...

The agreement is seen as a win for global health ahead of the US withdrawal from the WHO and amidst foreign aid cuts by the ...

Our editorial team dissects the latest developments in the ongoing story of how evolving US tariffs could impact the ...

The quality and compliance of the content foundation you build today helps your organization scale efficiently in the future.